Midodrine Hydrochloride Milstein (Midodrine Hydrochloride)

After oral intake, Midodrine is converted by the liver into desglymidodrine, an active metabolite that selectively stimulates peripheral alpha‑1 adrenergic receptors. This stimulation causes blood vessels to constrict, raising arterial pressure and improving circulation when a patient moves to an upright position.

The dosage of Midodrine Hydrochloride is individualized by the prescribing clinician based on the patient’s blood pressure response, severity of symptoms, and overall health status. The prescriber determines the appropriate strength, frequency, and titration schedule.

The safety of Midodrine Hydrochloride in pregnancy and lactation has not been definitively established. It is classified as pregnancy category unknown, and clinicians should weigh potential benefits against possible risks before prescribing to pregnant or nursing individuals.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Midodrine is a prodrug that directly stimulates peripheral alpha‑1 receptors, whereas other agents such as fludrocortisone increase blood volume or droxidopa act as a norepinephrine precursor. Midodrine’s rapid onset and short half‑life make it useful for patients needing quick, controllable blood pressure support.

Midodrine Hydrochloride tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

The medication is taken orally, usually with a full glass of water. It is commonly administered during the day, avoiding doses close to bedtime to reduce the risk of supine hypertension. Patients should follow the prescriber’s instructions regarding timing and food intake.

The most serious risks include severe supine hypertension, which can lead to cardiovascular complications, and rare allergic reactions such as angioedema. Patients should be monitored for signs of excessive blood pressure elevation, especially when lying down, and report any sudden chest pain or swelling.

Midodrine is contraindicated in patients with severe organic heart disease, uncontrolled hypertension, or known hypersensitivity to the drug. It should also be used with caution in individuals with renal impairment, urinary retention, or those taking other potent vasoconstrictors.